glp-1 dosage chart dose conversion and safe switching guide semaglutide dose in units GLP-1
Description
Levy J, Atkinson AB, Bell PM, McCance DR, Hadden DR
doi: 10.1002/msj.20159 [DOI] [PMC free article] [PubMed] [Google Scholar] 127
The information in this article is for educational purposes only and should not be considered medical advice
Conclusions While the advent of GLP-1R agonists have indisputably revolutionized the pharmaceutical intervention of obesity, further improvements in efficacy and tolerability are necessary to maximize the long-term health outcomes of patients
Learning how GIP affects lipid metabolism could help create new treatment options for obesity and other metabolic issues
PMID: 54 NicolauJNadalASanchsPPujolATamayoMINadalCet al
